Embio Limited, a active public limited company, was established on 20 January 1986 in Mumbai, Maharashtra, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24110MH1986PLC038680. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹43.62 Cr and a paid-up capital of ₹4.70 Cr.
Formerly known as Emmellen Biotech Pharmaceuticals Ltd. It upholds a compliant status. Employing 600 professional, Its leadership includes Madhusudan Rao Garimella (Director), Ajit Tekchand Vaswani (Director), Devesh Malladi (Managing Director). Past directors included Madhusudan Rao Garimella, Ajit Tekchand Vaswani, Mohan Rao Valluru. It holds ₹66.03 Cr open charges and ₹109.30 Cr settled loans. Its latest AGM occurred on 13 August 2024, with the balance sheet filed on 31 March 2024. It is based at 501 Sentinel, 5Th Floor, Hiranandani Gardens, Powai,, Mumbai, Maharashtra, 400076.
U24110MH1986PLC038680
038680
20 January 1986
₹43.62 Cr
₹4.70 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Embio Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Madhusudan Rao Garimella | Director | 07 Aug 2017 | Current |
| Ajit Tekchand Vaswani | Director | 16 Oct 2001 | Current |
| Devesh Malladi | Managing Director | 01 Oct 2007 | Current |
| Raghavachari Kasthuri Rangan | Director | 20 Sep 2024 | Current |
| Aadya Malladi | Additional Director | 26 Jun 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 08 Oct 2018 | Past |
| Pramod Abcsdd | Director | 19 Sep 2024 | Past |
| Pramod Abcsdd | Whole-Time Director | 28 May 2010 | Past |
| Pramod Abcsdd | Additional Director | 22 Sep 2008 | Past |
| Pramod Abcsdd | Director | 04 Jan 2022 | Past |
| Pramod Abcsdd | Secretary | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Embio Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 15.19% decrease. The company also saw a substantial fall in profitability, with a 87.83% decrease in profit. The company's net worth dipped by a decrease of 0.18%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Embio had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹660,300,000.00
₹1,093,022,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Mar 2022 | Axis Bank Limited | ₹25.00 Cr | Open |
| 10 Dec 2012 | Biotechnology Industry Research Assistance Council | ₹2.00 Cr | Open |
| 03 Dec 2002 | Axis Bank Limited | ₹25.00 Cr | Open |
| 28 Jun 1995 | State Bank Of India | ₹14.03 Cr | Open |
| 28 May 2015 | Hdfc Bank Limited | ₹3.00 M | Satisfied |
Explore comprehensive loan charge details -
Embio has a workforce of 600 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Embio, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Embio's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Aadya Malladi was appointed as a Additional Director was appointed as a Additional Director on 26 Jun 2025 & has been associated with this company since 5 months 4 days . was completed.
Progress on Raghavachari Kasthuri Rangan was appointed as a Director was appointed as a Director on 20 Sep 2024 & has been associated with this company since 1 year 2 months . was documented.
The activity Embio Limited last Annual general meeting of members was held on 13 Aug 2024 as per latest MCA records. was completed.
The activity Embio Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
Progress on A charge with Axis Bank Limited of Rs. 25.00 Cr registered on 07 Mar 2022 with Charge ID 100554671 was modified on 08 Sep 2022. was documented.
Progress on A charge with Axis Bank Limited of Rs. 25.00 Cr registered on 03 Dec 2002 with Charge ID 80046613 was modified on 08 Sep 2022. was documented.
The CIN of Embio Limited is U24110MH1986PLC038680.
Embio Limited is headquartered at 501 Sentinel, 5Th Floor, Hiranandani Gardens, Powai,, Mumbai, Maharashtra, 400076.
Embio Limited was incorporated on 20 January 1986.
The current directors of Embio Limited are
The primary industry of Embio Limited is Manufacturing.
Embio Limited is unlisted.
The authorized capital of Embio Limited is ₹43.62 Cr, and the paid-up capital is ₹4.70 Cr.
The compliance status of Embio Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX